Munafa Stock Market Course + Intraday & FNO calls 
EDIT NEWS why is Editas Medicine, Inc. price falling or rising
EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising
EDIT Editas Medicine is falling or rising technical reasons
Technical analysis forecast of Editas Medicine Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Editas Medicine EDIT at this time. Stock is rising and might rise more.
It appears as if Editas Medicine EDIT gave a large move recently.
Stock of Editas Medicine (EDIT) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.
My analysis of Editas Medicine is bullish for shortterm, and stock might move up till 3.3 or till 3.7. Use a stoploss of 3.01 and if this stock hits its stoploss, then it can fall down till 2.69
EDIT Editas Medicine is falling or rising NEWS fundamental reasons
Bandhan Bank targets 15% credit growth and ROA of 1.5% in FY27 as asset quality improves Bandhan Bank is showing signs of recovery, with its Managing Director and CEO highlighting a repaired balance sheet and cautious optimism for the future. The bank has seen NIMs stabilize due to lower funding costs and reduced slippages, while asset quality - NEWS as on 2026-04-29 indiatimes.com
IDFC First Bank deposit growth returning to 20%, credit costs falling, no West Asia impact yet: V Vaidyanathan IDFC First Bank's CEO V Vaidyanathan stated that the deliberate slowdown in deposit growth during Q4 was temporary and already reversing, with April data showing strong momentum. He expressed confidence in achieving 20% annual deposit growth in FY27, along - NEWS as on 2026-04-27 indiatimes.com
Tata Capital targets 23–25% loan growth through FY28, bets on GenAI and falling credit costs to boost returns Tata Capital anticipates strong performance in FY27, driven by growth, improved margins, and operating efficiency. The company has seen a consistent decline in credit costs, a trend expected to continue due to a disciplined risk culture and the adoption of - NEWS as on 2026-04-24 indiatimes.com
From swipe to strategy: Your credit card now decides what you buy Consumers now meticulously compare credit card offers before making purchases, turning transactions into value calculations. Credit cards are increasingly influencing buying decisions early in the cycle, acting as triggers for consumption and creating frag - NEWS as on 2026-04-22 indiatimes.com
India banks’ credit growth seen outpacing deposits in FY27: Analysts Bank credit growth is set to outpace deposit expansion in fiscal 2027. Analysts predict credit will grow 12-14% while deposits rise 10-12%. This trend follows a pattern where credit has consistently grown faster than deposits for over a decade. Revised liq - NEWS as on 2026-04-20 indiatimes.com
ETMarkets AIF Talk| Performing credit emerges as core portfolio allocation for investors: Amit Dharod India’s private credit market is emerging as a key part of alternative investments, supported by structural changes in lending and rising demand for stable returns. Once a niche, performing credit is becoming a core allocation, driven by a funding gap in m - NEWS as on 2026-04-16 indiatimes.com
U.S. Physical Therapy Closes 0 Mln Credit Facility (RTTNews) - U.S. Physical Therapy, Inc. (USPH), a chain of outpatient physical therapy clinics, Wednesday announced that it is closing a 0 million, five-year credit facility that includes a 5 million term loan and a 5 million revolver with a matur - NEWS as on 2026-04-15 nasdaq.com
Credit penetration among women rise 5-fold to Rs 76 lakh crore between 2017 and 2025 Women borrowers have seen a significant five-fold increase in credit access, reaching Rs 76 lakh crore by 2025. This represents 26% of all credit. Business loans for women have grown substantially, indicating a shift towards income-generating activities. D - NEWS as on 2026-04-13 indiatimes.com
More announcements and NEWS
EDIT Editas Medicine, Inc. current price & indicator signals
Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 28 Tue Apr 2026 | 3.06 | 2.86 to 3.08 | 5.52% | 0.83 times |
| 27 Mon Apr 2026 | 2.90 | 2.81 to 3.12 | -0.34% | 0.99 times |
| 24 Fri Apr 2026 | 2.91 | 2.88 to 3.33 | -9.35% | 0.79 times |
| 23 Thu Apr 2026 | 3.21 | 3.14 to 3.39 | -3.6% | 0.78 times |
| 22 Wed Apr 2026 | 3.33 | 3.28 to 3.47 | 0.91% | 0.72 times |
| 21 Tue Apr 2026 | 3.30 | 3.25 to 3.59 | -7.56% | 1.05 times |
| 20 Mon Apr 2026 | 3.57 | 3.37 to 3.65 | 2.29% | 1.2 times |
| 17 Fri Apr 2026 | 3.49 | 3.36 to 3.56 | 3.87% | 1.07 times |
| 16 Thu Apr 2026 | 3.36 | 3.22 to 3.40 | -0.3% | 0.84 times |
| 15 Wed Apr 2026 | 3.37 | 3.33 to 3.58 | -0.59% | 1.03 times |
| 14 Tue Apr 2026 | 3.39 | 3.23 to 3.55 | 5.94% | 1.52 times |
| 13 Mon Apr 2026 | 3.20 | 2.89 to 3.26 | 8.84% | 1.57 times |
Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
